価格表

在庫・価格 : 2025年10月08日 09時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human CCL18/PARC MAb (Clone 64507)
データシート※最新のデータシートでない場合があります
MAB394-500 RSDアールアンドディー システムズ
R&D Systems, Inc.
500 μg ¥259,000
(未発注)
追加

在庫・価格 : 2025年10月08日 09時00分 現在

Anti-Human CCL18/PARC MAb (Clone 64507)

  • 商品コード:MAB394-500
  • メーカー:RSD
  • 包装:500μg
  • 価格: ¥259,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Brencicova E et al. Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma. PLoS ONE 2017;12(4):e0175712
Brencicova E et al
2017/01/01
Species: Human, Applications: ELISA Development (Capture) PubMed
2 Quillinan N et al. Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis. Arthritis Res. Ther. 2017 Mar;19(1):45
Quillinan N et al
2017/01/01
Species: Human, Applications: ELISA Development (Capture) PubMed
3 Su S et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017 Apr;27(4):461-482
Su S et al
2017/01/01
Species: Human, Applications: ICC PubMed
4 Bruna-Romero O et al. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria. J. Immunol. 2003 Mar;170(6):3195-203
Bruna-Romero O et al
2003/01/01
Species: Mouse, Applications: ICC PubMed
5 Huang D et al. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages. Cancer Res. 2017 Jul;77(13):3591-3604
Huang D et al
2017/01/01
Species: Human, Applications: IHC PubMed
6 Pavlova EV et al. Potential biomarkers of osteonecrosis in Gaucher disease. Blood Cells Mol. Dis. 2011 Jan;46(1):27-33
Pavlova EV et al
2011/01/01
Species: Human, Applications: Luminex Development PubMed
7 Deegan PB et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore) 2011 Jan;90(1):52-60
Deegan PB et al
2011/01/01
Species: Human, Applications: Luminex Development PubMed
  • No.: 1
  • 文献情報:
    Brencicova E et al. Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma. PLoS ONE 2017;12(4):e0175712
    Brencicova E et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ELISA Development (Capture)
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Quillinan N et al. Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis. Arthritis Res. Ther. 2017 Mar;19(1):45
    Quillinan N et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ELISA Development (Capture)
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Su S et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017 Apr;27(4):461-482
    Su S et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Bruna-Romero O et al. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria. J. Immunol. 2003 Mar;170(6):3195-203
    Bruna-Romero O et al
    2003/01/01
  • 備考:
    Species: Mouse, Applications: ICC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Huang D et al. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages. Cancer Res. 2017 Jul;77(13):3591-3604
    Huang D et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Pavlova EV et al. Potential biomarkers of osteonecrosis in Gaucher disease. Blood Cells Mol. Dis. 2011 Jan;46(1):27-33
    Pavlova EV et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Deegan PB et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore) 2011 Jan;90(1):52-60
    Deegan PB et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Luminex Development
  • 参照:
    PubMed